CME/CE

The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care

Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis

Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines

Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes

Treating Patients With T2D and MASLD: Is the Tide Changing?

I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?

MASLD in My Clinic: Hiding in Plain Sight?

Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice

Overcoming Clinical Inertia in Hyperkalemia Management

Curbside Consult: Optimizing IgAN Management

Getting to the Root of CKD-Associated Pruritus: Questions From the Field

Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP

Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD